How should a rash in the axillae and groin of an HIV-positive patient be evaluated and treated?

Evaluation and Treatment of Rash in Axillae and Groin in HIV-Positive Patients

In an HIV-positive patient presenting with rash in the armpits and groin, the most likely diagnosis is cutaneous candidiasis (intertrigo), and you should initiate treatment with topical azoles (clotrimazole, miconazole, or terconazole) for 3-7 days, while simultaneously evaluating for other common HIV-associated dermatoses and ensuring the patient is on antiretroviral therapy.

Diagnostic Approach

The intertriginous distribution (axillae and groin) in an HIV patient strongly suggests candidiasis, which commonly affects warm, moist areas including the inguinal and anal clefts 1, 2. However, you must systematically exclude other possibilities:

Key Clinical Features to Assess:

• Lesion morphology: Satellite pustules and erythematous base suggest candidiasis; papular lesions may indicate pruritic papular eruption (PPE); scaling plaques suggest dermatophytosis
• CD4+ count: Severe immunosuppression (CD4+ <50 cells/µL) increases risk of refractory candidiasis and unusual presentations 2
• Pruritus severity: Intense itching may indicate PPE, eosinophilic folliculitis, or dermatophyte infection 3, 4
• Concurrent infections: Check oral mucosa for thrush, examine for other skin lesions 3

Essential Diagnostic Steps:

1. Obtain skin scrapings for KOH preparation and fungal culture to confirm diagnosis 5
2. Check CD4+ count and HIV viral load if not recently done
3. Examine for coexisting infections: Candida albicans (42.9% of cases) and bacterial superinfection are common 3
4. Review antiretroviral therapy status - untreated HIV significantly worsens outcomes 2

Treatment Algorithm

First-Line Treatment for Suspected Candidiasis:

Topical azoles are the initial treatment of choice 1, 2:

• Clotrimazole, miconazole, or terconazole cream applied twice daily for 3-7 days
• Alternative: Nystatin 100,000 units daily for 14 days (less effective, second-line)

When to Escalate to Systemic Therapy:

If lesions are extensive, severe, or fail to respond within 48-72 hours 2:

• Oral fluconazole 150 mg single dose for uncomplicated cases 2
• Complicated/refractory cases: Fluconazole or topical therapy for >7 days 1, 2
• Itraconazole oral solution 200 mg twice daily for 1 day or 200 mg daily for 3 days (alternative, less well tolerated) 2

If Dermatophytosis (Tinea Cruris) is Confirmed:

Dermatophyte infections are more severe in HIV patients and prone to recurrence 6, 5:

• Topical azoles, terbinafine, or ciclopirox olamine for localized disease 5
• Systemic therapy (ketoconazole, fluconazole, or itraconazole) for chronic/extensive disease 6, 5

If Pruritic Papular Eruption (PPE) is Suspected:

PPE commonly affects arms, chest, back, and can involve groin/anal cleft 3:

• Initiate or optimize antiretroviral therapy - this is the cornerstone of treatment 3
• Adjuvant corticosteroids (topical or systemic) for symptomatic relief 3
• UVB phototherapy for refractory pruritus 3, 4, 7
• Screen for concurrent infections (Candida, Treponema pallidum, Demodex) 3

Critical Management Points

Antiretroviral Therapy is Essential:

ART reduces the frequency of mucosal and cutaneous candidiasis and resolves refractory cases when immunity improves 2. If the patient is not on ART or has poor viral suppression, addressing this is as important as treating the rash itself.

Monitor for Treatment Response:

• Expect improvement within 48-72 hours of appropriate therapy 2
• If no improvement, reconsider diagnosis or check for azole-resistant organisms 2

Common Pitfalls to Avoid:

1. Don't assume idiopathic HIV-pruritus without excluding specific dermatoses - this is a diagnosis of exclusion 4, 7
2. Don't use prophylactic corticosteroids when starting treatment - they don't prevent rash and may worsen outcomes 8
3. Don't overlook drug eruptions - HIV patients have higher rates due to immune dysregulation and polypharmacy 7
4. Don't forget to check for STIs - concurrent syphilis occurs in 42.9% of PPE cases 3

When to Consider Alternative Diagnoses:

If initial treatment fails or presentation is atypical, consider:

• Seborrheic dermatitis (responds to ketoconazole or low-potency topical steroids) 6, 5
• Eosinophilic pustular folliculitis (may respond to high-dose itraconazole) 6
• Drug eruption from antiretrovirals or other medications 8, 7
• Bacterial folliculitis (requires antibiotics) 4

Long-Term Management:

Secondary prophylaxis is generally NOT recommended for recurrent candidiasis due to cost, drug interactions, and risk of resistance 1, 2. However, if recurrences are frequent and severely impact quality of life, consider oral fluconazole prophylaxis 2.

The key to successful management is treating the immediate infection while simultaneously optimizing HIV control through ART, which addresses the underlying immunosuppression driving these dermatologic complications 2.